These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Koren G, Clark S, Hankins GD, Caritis SN, Miodovnik M, Umans JG, Mattison DR. Am J Obstet Gynecol; 2010 Dec; 203(6):571.e1-7. PubMed ID: 20843504 [Abstract] [Full Text] [Related]
3. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study. Pope E, Maltepe C, Koren G. J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469 [Abstract] [Full Text] [Related]
4. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M, Mattison DR, Matok I. BMC Pregnancy Childbirth; 2016 Nov 24; 16(1):371. PubMed ID: 27881103 [Abstract] [Full Text] [Related]
12. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M, Mattison DR, Matok I. BMC Pregnancy Childbirth; 2015 Mar 18; 15():59. PubMed ID: 25884778 [Abstract] [Full Text] [Related]
14. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy. Madjunkova S, Maltepe C, Koren G. Paediatr Drugs; 2014 Jun 18; 16(3):199-211. PubMed ID: 24574047 [Abstract] [Full Text] [Related]
15. Flawed invisible trial underpins US morning sickness drug, researchers say. Dyer O. BMJ; 2017 Jan 09; 356():j132. PubMed ID: 28069575 [No Abstract] [Full Text] [Related]
16. Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis. Persaud N, Meaney C, El-Emam K, Moineddin R, Thorpe K. PLoS One; 2018 Jan 09; 13(1):e0189978. PubMed ID: 29342163 [Abstract] [Full Text] [Related]
18. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy. Costantine MM, Matok I, Chiossi G, Clark S, Miodovnik M, Umans JG, Caritis S, Hankins GD, Koren G. Ther Drug Monit; 2012 Oct 09; 34(5):569-73. PubMed ID: 22972538 [Abstract] [Full Text] [Related]
19. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy. Ashkenazi-Hoffnung L, Merlob P, Stahl B, Klinger G. Isr Med Assoc J; 2013 Jan 09; 15(1):23-6. PubMed ID: 23484234 [Abstract] [Full Text] [Related]